Showing results (151-160 of 164) with videos related to

Sort By:
Pageof 17
Clinical & Experimental Ophthalmology|June 20, 2013
Uveitis in human immunodeficiency virus-infected persons with CD4+ T-lymphocyte count over 200 cells/mLJennifer Rose-Nussbaumer, Debra A Goldstein, Jennifer E Thorne, et al.
JAMA Ophthalmology|June 25, 2026
Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction: Follow-Up of a Randomized Clinical TrialN Venkatesh Prajna, Alec Bernard, Lalitha Prajna, et al.
JAMA Ophthalmology|March 13, 2015
Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical TrialJennifer Rose-Nussbaumer, N Venkatesh Prajna, K Tiruvengada Krishnan, et al.
JAMA Ophthalmology|April 21, 2017
Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial IIN Venkatesh Prajna, Tiruvengada Krishnan, Revathi Rajaraman, et al.
Indian Journal of Ophthalmology|March 8, 2024
Locality is the strongest predictor of expert performance in image-based differentiation of bacterial and fungal corneal ulcers from IndiaChristopher R Rosenberg, Venkatesh Prajna, Muthiah K Srinivasan, et al.
JAMA Ophthalmology|October 28, 2016
Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): A Randomized Clinical TrialN Venkatesh Prajna, Tiruvengada Krishnan, Revathi Rajaraman, et al.
BMJ Open|December 22, 2019
A double masked randomised 4-week, placebo-controlled study in the USA, Thailand and Taiwan to compare the efficacy of oral valganciclovir and topical 2% ganciclovir in the treatment of cytomegalovirus anterior uveitis: study protocolJaskirat S Takhar, Ashlin S Joye, Thanapong Somkijrungroj, et al.
The British Journal of Ophthalmology|November 5, 2015
Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazoleJennifer Rose-Nussbaumer, N Venkatesh Prajna, Tiruvengada Krishnan, et al.
BMJ Open Ophthalmology|October 1, 2024
Descemet Endothelial Thickness Comparison Trial II (DETECT II): multicentre, outcome assessor-masked, placebo-controlled trial comparing Descemet membrane endothelial keratoplasty (DMEK) to Descemet stripping only (DSO) with adjunctive ripasudil for Fuchs dystrophyCharles C Lin, Winston Chamberlain, Beth Ann Benetz, et al.
Blood|May 7, 2016
Pathophysiological significance and therapeutic targeting of germinal center kinase in diffuse large B-cell lymphomaJulie Marie Matthews, Shruti Bhatt, Matthew P Patricelli, et al.
Pageof 17